Inventor · Mill Valley, CA, US

Hideho Okada

19Patents
5h-index
24Co-inventors
66Inventor score

Filing activity: Mar 5, 1997 → Oct 22, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US9394368B2 Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor Chemistry; Metallurgy 94 Active
US5952221A Adeno-associated virus vectors comprising a first and second nucleic acid sequence Chemistry; Metallurgy 68 Expired
US7612162B2 Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response Human Necessities 18 Expired
US6218180A Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors Chemistry; Metallurgy 12 Expired
US8486911B2 Th1-associated microRNAs and their use for tumor immunotherapy Chemistry; Metallurgy 11 Active
US8859488B2 Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response Human Necessities 5 Active
US10441644B2 H3.3 CTL peptides and uses thereof Human Necessities 3 Active
US10434155B2 Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response Human Necessities 2 Active
US10849965B2 H3.3 CTL peptides and uses thereof Human Necessities 2 Active
US9675642B2 Engineered dendritic cells and uses for the treatment of cancer Physics 2 Active
US10308717B2 Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor Chemistry; Metallurgy 2 Active
US10874730B2 Methods for treating brain cancer using il-13r alpha 2 peptide-based compositions Human Necessities 1 Active
US11865167B2 Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor Chemistry; Metallurgy 1 Active
US12090170B2 Methods of treating glioblastomas Chemistry; Metallurgy 0 Active
US12144826B2 Methods of treating EGFRvIII expressing glioblastomas Chemistry; Metallurgy 0 Active
US10617667B2 Method for treating brain tumors Human Necessities 0 Active
US11925679B2 H3.3 CTL peptides and uses thereof Human Necessities 0 Active
US11723963B2 Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response Human Necessities 0 Active
US11185577B2 H3.3 CTL peptides and uses thereof Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.